[关键词]
[摘要]
目的:探讨终末糖基化产物(advanced glycation end products,AGEs)对结肠癌SW620细胞上皮间质转化(epithelial-to-mesenchymal transition, EMT)及肿瘤干细胞标志物CD133的影响及其作用机制。方法:用不同浓度(0、50、100、200 μg/ml)的AGEs处理SW620细胞后,采用划痕实验检测细胞的迁移能力;Transwell小室检测细胞的侵袭能力;流式细胞术检测CD133+细胞的含量;Western blotting检测AGEs受体(receptor of AGEs,RAGE)、E-cadherin、Vimentin、ERK1/2、p-ERK1/2、CD133蛋白的表达情况。结果: 与对照组(0 μg/ml)比较,AGEs处理组(50、100、200 μg/ml)在AGEs作用后,SW620细胞24 h迁移距离\[(1.55±0.15)、(158±0.19)、(1.75±0.21)vs (0.95±0.18) mm,均P<0.05\]及48 h迁移距离\[(211±022)、(2.21±037)、(2.68±023)vs (1.60±0.24) mm,均P<0.05\]均明显增加;穿过Matrigel胶的数量明显增加\[(176±19.52)、(194±17.70)、(220±25.5)vs (125±26.06) 个,均P<0.05\];CD133+细胞比例明显增加\[(4.75±149)、(10.34±1.54)、(14.45±2.41)% vs (0.77±0.41),均P<0.05\]。与对照组比较,AGEs处理组(50、100、200 μg/ml)Vimentin、RAGE、p-Erk1/2、CD133蛋白表达明显增加;而ERK1/2蛋白无明显变化;E-cadherin蛋白表达明显减少。结论: AGEs可以提高结肠癌SW620细胞体外的侵袭迁移能力,促进EMT的发生,诱导肿瘤干细胞的生成。其机制可能通过AGE-RAGE受体配体的激活,上调p-ERK1/2,从而调控EMT相关蛋白的表达,促进肿瘤干细胞的生成。
[Key word]
[Abstract]
Objective:To investigate the effect of advanced glycation end products(AGEs) on epithelial-mesenchymal transition (EMT) and cancer stem cell associated marker CD133 in human colon cancer cell line SW620 and their mechanism of actions. Methods:After the SW620 cells were treated with AGEs at different concentrations of 0,50,100,200μg/ml, migration and invasion abilities of the SW620 cells were detected by wound healing test and Transwell chamber assay, respectively, percentage of CD133+ cells was tested by flow cytometry, and protein expression levels of receptor of AGEs(RAGE), E-cadherin, Vimentin, ERK1/2, p-ERK1/2 and CD133 were detected by Western blotting. Results: After the treatment of AGEs, compared with the control group (0 μg/ml), cellular migration distances in experiment groups (50, 100, 200 μg/ml) were significantly improved after 24 h (\[1.55±0.15\], \[1.58±0.19\], \[1.75±0.21\] vs \[0.95±0.18\] mm,all P<0.05) and 48 h (\[1.60±0.24\], \[2.11±0.22\], \[2.68±0.23\] vs \[1.60±0.24\] mm, all P<005). In addition, treating the cells with AGEs (50,100, 200 μg/ml) for 48 h remarkably increased number of the cells crossed Matrigel in vitro( \[176±19.52\], \[194±17.70\], \[220±25.50\] vs \[125±26.06\],all P<0.05\] and percentages of CD133+ cell (\[4.75±1.49\], \[10.34±1.54\], \[14.45±2.41\]% vs \[0.77±0.41\]%,all P<0.05). Expressions of RAGE, Vimentin, p-ERK1/2 and CD133 proteins were significantly increased in the treatment groups comparing with control group; however, the expression of E-cadherin protein was decreased, while that of ERK1/2 protein had not obvious change. Conclusion: AGEs could enhance migration and invasion abilities of the SW620 cells in vitro, promote occurrence of EMT, and induce tumorigenesis of cancer stem cells. Activating ligand of AGE-RAGE, up-regulating p-ERK1/2 prtein and regulating expression of the EMT protein might be a possible mechanism for tumorigenesis of cancer stem cells.
[中图分类号]
[基金项目]
重庆市自然科学基金资助项目(No.cstc2012jjA0038)